Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of MSA-01 in Multiple System Atrophy
jRCT2031250696Phase 3Recruiting
- Sponsor
- Not applicable
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple system atrophy (MSA) comparing MSA-01 arm with Placebo arm (2 arms). Started Feb 2026; status: recruiting.
02
Drugs
ubiquinol
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on jRCT2031250696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250696.